TerminatedPhase 4NCT01310738
Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil
Studying Leishmaniasis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Brasilia
- Principal Investigator
- Carlos HN Costa, MD PhDFederal University of Piaui
- Intervention
- Antimoniate of N-methylglucamine(drug)
- Enrollment
- 378 target
- Eligibility
- 50 years · All sexes
- Timeline
- 2011 – 2015
Study locations (5)
- Hospital Universitário da Universidade Federal de Sergipe, Sergipe, Aracaju, Brazil
- Hospital São José de Doenças Infecciosas, Fortaleza, Ceará, Brazil
- Hospital Infantil João Paulo II - FHEMIG, Belo Horizonte, Minas Gerais, Brazil
- Hospital Universitário Clemente de Faria - Universidade Estadual de Montes Claros, Montes Claros, Minas Gerais, Brazil
- Hospital de Doencas Infecto Contagiosas - HDIC, Teresina, Piauí, Brazil
Collaborators
Ministry of Health, Brazil · Drugs for Neglected Diseases · Conselho Nacional de Desenvolvimento Científico e Tecnológico
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01310738 on ClinicalTrials.govOther trials for Leishmaniasis
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07487350Recurrent Visceral Leishmaniasis in HIV Co-InfectionInstitute of Tropical Medicine, Belgium
- ACTIVE NOT RECRUITINGNANCT06983665Human Bioequivalence Study of Liposomal Amphotericin B for InjectionSichuan Huiyu Pharmaceutical Co., Ltd
- RECRUITINGPHASE2NCT06798415Intralesional Injection of Metronidazole for the Management of Cutaneous LeishmaniasisHayder Adnan Fawzi
- RECRUITINGPHASE2NCT06797544Intralesional Injection of Levofloxacin for the Management of Cutaneous LeishmaniasisHayder Adnan Fawzi
- RECRUITINGPHASE2NCT06798402Ciprofloxacin Intralesional Injection for the Treatment of Cutaneous Leishmaniasis Compared to Sodium StibogluconateAl-Mustafa University College
- RECRUITINGPHASE2NCT06550609Treatment of Bolivian L Braziliensis Mucosal Leishmaniasis with Inhaled Pentamidine Plus Oral MiltefosineFundacion Nacional de Dermatologia
- RECRUITINGNCT06514560OPTImizing MIltefosine Treatment for Cutaneous LEISHmaniasis PatientsInstitute of Tropical Medicine, Belgium
- RECRUITINGNANCT06307171Human Leishmaniasis: Antigen Recognition Pattern and Study of New Potential BiomarkersIRCCS Sacro Cuore Don Calabria di Negrar